// App-Quantinova.ai

: Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)

Researchers

Presenter

  • Tiziano Barbui

Principal Investigators

  • Arianna Ghirardi

  • Alessandra Iurlo

  • Valerio De Stefano

  • Marta Anna Sobas

  • Elisa Rumi

  • Elena Maria Elli

  • Francesca Lunghi

  • Mercedes Gasior Kabat

  • Beatriz Cuevas

  • Paola Guglielmelli

  • Massimiliano Bonifacio

  • Monia Marchetti

  • Alberto Alvarez-Larran

  • Laura Maria Fox

  • Marta Bellini

  • Rosa Daffini

  • Giulia Benevolo

  • Gonzalo Carreño

  • Andrea Patriarca

  • Haifa Kathrin Al-Ali

  • Marcio Andrade

  • Francesca Palandri

  • Claire Harrison

  • Maria Angeles Foncillas

  • Santiago Osorio

  • Steffen Koschmieder

  • Elena Magro

  • Jean-Jacques Kiladjian

  • Estefanía Bolaños

  • Florian H. Heidel

  • Keina Quiroz

  • Martin Griesshammer

  • Valentin Garcia Gutierrez

  • Alberto Marin Sanchez

  • Juan Carlos Hernandez Boluda

  • Emma Lopez Abadia

  • Giuseppe Carli

  • Miguel Sagues

  • Rajko Kusec

  • Blanca Xicoy

  • Margarita Guenova

  • Begona Navas

  • Anna Angona

  • Edyta Cichocka

  • Anna Masternak

  • Daniele Cattaneo

  • Cristina Bucelli

  • Silvia Betti

  • Oscar Borsani

  • Fabrizio Cavalca

  • Sara Carbonell

  • Natalia Curto-Garcia

  • Lina Benajiba

  • Alessandro Rambaldi

  • Alessandro M. Vannucchi

Medical Centers

  • Laboratory of Hematopathology & Immunology, National Specialised Hospital for Active Treatment of Hematological Diseases, Sofia, BGR

  • Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland

  • Department of haematology, Clinic of internal medicine, University Hospital Dubrava-School of Medicine University of Zagreb, Zagreb, Croatia

  • Guy's and St Thomas’ NHS Foundation Trust, London, United Kingdom

  • HOSPITAL CLINICO SAN CARLOS, MADRID, Spain

  • FROM Research Foundation Ospedale di Bergamo, Bergamo, Italy

  • San Gerardo Hospital, ASST Monza, Monza, Italy

  • Hôpital Saint-Louis, Université de Paris, Paris, France

  • Hospital Universitario La Paz, Madrid, ESP

  • Hematology Division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

  • Hospital General U. Gregorio Marañón, Madrid, Spain

  • HU German Trias i Pujol - Institut Català d’ Oncologia, Barcelona, Spain

  • Department of Molecular Medicine, University of Pavia, Pavia, Italy

  • Hopital Saint-Louis, Paris, France

  • Department of Hematology, ASST Spedali Civili, Brescia, Italy

  • Department of hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Barcelona, Spain

  • Hematology Department, Hospital Clínic, Barcelona, Spain

  • Department of Hematology and Hematooncology, District Specialist Hospital, Opole, Opole, Poland

  • Department of Hematology and Bone Marrow Transplantation, Copernicus Memorial Hospital, Torun, Poland

  • University of Milan, Milan, Italy

  • Hematology Unit, Department of Translational Medicine, University of Eastern Piedmont and AOU Maggiore della Carità, Novara, Italy

  • Department of Hematology, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, VALENCIA, Spain

  • Department of Hematology, S. Bortolo Hospital, Vicenza, Vicenza, Italy

  • Hospital Universitario de Móstoles, Madrid, Spain

  • CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

  • Hematology Division and Bone Marrow Transplant Unit, San Gerardo Hospital, ASST Monza, Monza, Italy

  • University Clinic for Hematology, Oncology, Haemostaseology and Palliative Care, Johannes Wesling Medical Center, Minden, University of Bochum, Minden, Germany

  • Hospital General De Elche, Elche, Alicante, Spain

  • Hematology Department, Hospital Universitario de Octubre, Instituto de Investigación Sanitaria Imas, Madrid, Spain

  • Krukenberg Cancer Center Halle, University Hospital Halle (Saale), Halle/ Saale, Germany

  • Hematology and hemotherapy department, Hospital Universitario HLA Moncloa, Madrid, Spain

  • Hematology, Hospital Universitario de Burgos, BURGOS, ESP

  • Department of Onco-Haematology - Haematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute and Vita-Salute Hospital, Milano, Italy

  • Hospital General Universitario De Albacete, Albacete, ESP

  • Hospital Universitario Infanta Leonor, Madrid, Spain

  • Division of Hematology, Hospital Antonio e Biagio and Cesare Arrigo, Alessandria, Italy

  • Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy

  • Innere Medicin C, Universitätsmedizin Greifswald, Greifswald, Germany

  • Department of Medicine, Section of Hematology, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy

  • Hospital Universitario Principe de Asturias, Alcalá de Henares, Spain

  • Hospital de Sant Joan Despí Moisès Broggi, Sant Joan Despí, Barcelona, Spain

  • Hematology Service, Hospital Universitario Ramón y Cajal. IRYCIS, Madrid, Spain

  • HU Dr. J Trueta - Institut Català d'Oncologia, Girona, Spain

  • Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, University Hospital of Aachen, Aachen, Germany

Locations

  • Bulgaria

  • Italy

  • Spain

  • Poland

  • France

  • Croatia

  • Germany

  • United Kingdom

  • Uruguay

  • Philippines

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved